Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01574404 · ClinicalTrials.gov registry record · NA
Polar Body Biopsy for Preimplantation Genetic Screening
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 33
- Enrollment target
NCT01574404 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 33 participants.
The verdict
NCT01574404, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 33 participants
- Enrollment target
Study Summary
People with infertility undergoing in vitro fertilization (IVF) can test the embryos using a method called preimplantation genetic screening (PGS) before they are implanted in the uterus to possibly increase their chances of having a successful pregnancy. One or more cells are removed from the embryo. The chromosomes inside the cells are then tested to identify normal or aneuploid embryo(s). The investigators propose to evaluate a test called micro array analysis on the chromosomes of the first polar body. This method tests part of the egg that would normally be lost and may help us choose the embryo most likely to become a healthy baby.
Interventions
- PROCEDURE Polar body biopsy with PGS
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01574404
The ClinicalTrials.gov registry entry for NCT01574404 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 33 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Polar body biopsy with PGS is the first listed.
NCT01574404 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01574404 about?
NCT01574404 is a clinical study titled "Polar Body Biopsy for Preimplantation Genetic Screening". People with infertility undergoing in vitro fertilization (IVF) can test the embryos using a method called preimplantation genetic screening (PGS) before they are implanted in the uterus to possibly increase their chances of having a successful pregnancy. One or more cells are removed from the embry...
What is the current status of trial NCT01574404?
This trial is currently completed. It is a NA study. The enrollment target is 33 participants. The study started on 2011-09. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01574404?
The interventions under investigation include: Polar body biopsy with PGS (PROCEDURE).
Who is sponsoring clinical trial NCT01574404?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.